Our network of internationally recognized academic leaders contribute to the design, conduct and interpretation of clinical trials in the field of immunology and vaccinology. Combined with operational excellence, this scientific expertise uniquely qualifies us as an attractive partner during the clinical development process. To customers, we are the ‘right size’ full-service clinical CRO: big enough to deliver, small enough to care.
We collaborate within a vast network of leading clinics and research centers in immunology and vaccinology, offering access to world-class scientific expertise and subject populations.
We are preferred partner in several large subsidized consortium studies, funded through e.g. Horizon2020 and CEPI.
We manage clinical operations and partnerships globally, with a strong presence across the European continent.
We have a strong track-record of designing and managing early-stage clinical safety, feasibility and concept-efficacy projects.
We partner with eClinical innovators to promote research data integrity, auditability, and system interoperability, enabling us to provide best value for money to our clients.
We deliver custom-tailored services and adapt quickly to changing requirements.
At CR2O, we have a highly motivated and experienced cross-functional team that helps you to effectively bring your project to the clinic. Our integrated project teams enable seamless transition between the domains we service.
While covering a broad range of therapeutic areas, our primary expertise lies in the immunology and infectious disease domain, across all phases (I-IV). There, we have worked together with 75+ study centres across the globe. Prof. dr. Ab Osterhaus, our CSO and a world-renowned virologist, firmly believes that the development of intervention strategies for human infectious diseases can be accelerated through the clinical programs supported by CR2O.
